Recombinant Human FLJ12644 protein (His-DHFR tag N-Terminus)
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human FLJ12644 protein (His-DHFR tag N-Terminus) is a Human Fragment protein, in the 96 to 386 aa range, expressed in Escherichia coli, with >95%, suitable for SDS-PAGE.
View Alternative Names
Zinc finger protein 649, ZNF649
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The function of LRRC59 influences multiple aspects of cell signaling and homeostasis. It appears to be a part of multiprotein complexes that affect protein localization. These complexes are important for directing proteins to specific cellular compartments. Interaction with other proteins allows LRRC59 to regulate the distribution of signaling molecules within different regions of the cell maintaining efficient cellular communication.
Pathways
LRRC59 serves an important role in the MAPK signaling pathway and the nuclear localization sequence recognition process. The MAPK signaling pathway involves various proteins like ERK which are important for cell proliferation and differentiation. LRRC59 also interacts with importins in guiding proteins into the nucleus. These interactions highlight the role of LRRC59 in dynamic cellular responses and signal propagation.
Specifications
Form
Lyophilized
Additional notes
Purified via His tag
General info
Function
Transcriptional repressor. Regulator of transcriptional factor complexes and may suppress SRE and AP-1 transcription activities mediated by growth factor signaling pathways.
Sequence similarities
Belongs to the krueppel C2H2-type zinc-finger protein family.
Subcellular localisation
Nucleus
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com